As a result, current clinical guidelines for T2DM, kidney disease, and cardiovascular care strongly recommend the use of GLP-1RAs and SGLT2is in patients with T2DM who have, or are at high risk for, atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), or chronic kidney disease (CKD)
C57BL/6 mice (7/8-week-old females) were purchased from Chongqing Enbi Biotechnology Co
Fourniers gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials
Can I schedule an appointment if I live anywhere in Indiana
Petrella C, Di Certo M, Gabanella F, Barbato C, Ceci F, Greco A, Ralli M, Polimeni A, Angeloni A, Severini C, Vitali M, Ferraguti G, Ceccanti M, Lucarelli M, Severi C, Fiore M (2021) Mediterranean diet, brain and nuscle: olive polyphenols and resveratrol protection in neurodegenerative and neuromuscular disorders
& Landstrom, A